Skip to content

A study to evaluate effectiveness of sublobar resection with lymphadenectomy in patients with non-small cell lung cancer

A multi-centre real-world observational study to evaluate effectiveness of sublobar resection with lymphadenectomy in patients with non-small cell lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014804
Enrollment
Unknown
Registered
2018-02-07
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Surgeries plus lymphadenectomy:Surgeries plus lymphadenectomy

Sponsors

Tongji Hospital Affiliated to Huazhong Technology University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: All the patients who met all of the following inclusion criteria will be included in the study: 1. Patients with age >= 18 years; 2. Patients who received sublobar resection and were enrolled in clinics from 2014 to 2017; 3. Patients with selective or systematic lymphadenectomy; 4. Patients with clinical staging I and II lung cancer; 5. Diagnosed patients with non-small cell lung cancer after surgeries.

Exclusion criteria

Exclusion criteria: All the patients who met any one of the following exclusion criteria will be excluded in the study: 1. Patients who were previously administered with cancer treatments (including chemotherapies, radiotherapies, target therapies, etc); 2. Late-phase Patients or those patients who were not intolerant to lobar surgery of palliative resection and compromise sublobar resection.

Design outcomes

Primary

MeasureTime frame
Overall survival;Overall survivals in the subgroups categorised by tumor biological characteristics;

Countries

China

Contacts

Public ContactXiangning Fu

Tongji Hospital Affiliated to Huazhong Technology University

Fuxn2006@aliyun.com+86 13607150390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026